Identifying cannabis types by appearance can describe visible traits, but it cannot reliably establish a plant's THC or CBD content, its exact ancestry or the effects of a product made from it. Broad leaves, narrow leaves and a compact or open shape are observations. They are not laboratory results.
If you have encountered an indica, sativa or hybrid comparison chart, this guide explains how to read it without asking the picture to prove too much. We separate botanical names, commercial labels and visible characteristics, then show which questions require a different kind of evidence. The focus is identification and terminology, not growing methods or selecting cannabis for a particular effect.
A botanical name and a shop label do different jobs
Botanical classification aims to identify and organise plants. Commercial labels may describe a named product, a claimed lineage or a familiar category used by a seller. The same words can appear in both settings without carrying the same meaning.
Kew's Plants of the World Online accepts Cannabis sativa L. and lists Cannabis indica Lam. among its synonyms. That is a statement about the treatment in this taxonomic database. It does not mean that every commercial “sativa” label identifies a uniform chemical product.
When reading a label, first establish which question it is answering. Is it a botanical identification, a cultivar name, a seller's category or a chemical test result? Confusion begins when one is treated as evidence for another.
Why the familiar appearance chart has limits
Traditional comparisons often depict indica as broad-leaved and compact, and sativa as narrow-leaved and taller. Such illustrations are simplified descriptions of contrasting forms. They are not a diagnostic key that proves the category of every contemporary plant.
Fixed heights and predictable chemical effects cannot be established from those simplified descriptions. A photograph can show the shape of the photographed plant at that moment; it does not establish a universal size, a percentage of ancestry or a cannabinoid profile.
“Hybrid” does not solve this problem by placing every plant neatly halfway between two drawings. A commercial hybrid label is not a promise that every visible feature will be intermediate, nor a measured statement about how a product will affect someone.
An appearance photograph does not identify a chemical profile.
Describe what is visible, then stop at that boundary
| Visible observation | What you can record | What the observation does not prove |
|---|---|---|
| Leaf form | Relative leaflet width and arrangement in the image | Exact lineage, THC or CBD content |
| Plant outline | Compact or open appearance in that view | A fixed mature height or commercial category |
| Colour | Colour under the recorded lighting conditions | Chemical composition or product quality |
| Flower appearance | Visible shape and surface detail | Potency, safety or a medical effect |
| Seller's label | The category the seller assigned | Independent confirmation of ancestry or chemistry |
For a photograph, note whether there is a scale, whether the whole plant is visible and how the image was made. A close crop of one leaf provides different information from a complete specimen. Strong colour casts or image edits further limit what can be inferred from the photograph.
This is an observation record, not a cultivation assessment. It is acceptable to write “not established from this image” rather than force a confident category onto an uncertain example.
Visible flower detail is not a potency test.
Phenotype, genotype and chemotype are different descriptions
Phenotype describes observable characteristics, while genotype concerns genetic information. Chemotype describes chemical characteristics. These terms help keep a question precise: an image supplies information about appearance, while genetic or chemical claims need the relevant analysis and a traceable sample.
You may see a seller move from a visible trait to an effect claim in one sentence. For example, a broad leaf is presented as proof of a CBD-rich or calming product. The first part describes appearance; the second requires evidence that the picture does not provide.
The same distinction applies to strain names. A familiar name can help identify what a seller calls a product, but it is not a substitute for a documented sample record.
What does research say about indica and sativa labels?
Dalhousie University's report of its 2021 study describes indica and sativa labels as poor predictors of the samples' overall genetics and chemistry. The researchers also found associations involving a small number of aroma compounds, so the result should not be simplified into “no differences of any kind exist”.
The practical limit is narrower: a broad category or strain name does not reliably tell you the complete composition of an individual sample. This research concerns labelled samples; it is not a validation of a visual identification app or a photograph-based potency test.
Avoid extending the result into medical advice. Neither a label nor a leaf image establishes that a product will treat a condition or produce a particular response.
What evidence would answer the remaining question?
If the question concerns botanical identity, look for a documented identification with enough specimen information to support it. If it concerns a commercial product, establish the exact product and batch. If it concerns chemistry, the relevant evidence is an analysis traceable to that sample, with the measured substances and method identified.
A certificate referring to another sample does not answer the question about the item in front of you. Nor does a photograph of resin or a colourful label replace that connection. Keep the identification and the supporting record together.
For unfamiliar terms, start with what weed, cannabis and dagga mean. Questions about permissions in South Africa belong to the separate cannabis law guide, not to a visual category chart. Appearance can begin a description; it should not be made to finish a chemical, medical or legal conclusion.